About
Proskope develops a blood-based diagnostic test that leverages the immune system as a biosensor to detect cancer early, with an initial focus on colorectal cancer; the test is designed to deliver results within hours.
Explore Proskope's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.